minaprine has been researched along with Depression, Endogenous in 12 studies
minaprine: Agr 1240 refers to di-HCl; short-acting type A MAO inhibitor (MAOI) of mild potency; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| ") in the treatment of major depressive disorders (DSM-III) were compared with those of imipramine (50 b." | 9.06 | Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study. ( Bizière, K; Bohacek, N; Ravic, M, 1987) |
| ") in the treatment of major depressive disorders (DSM-III) were compared with those of imipramine (50 b." | 5.06 | Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study. ( Bizière, K; Bohacek, N; Ravic, M, 1987) |
| "Platelet 3H-imipramine binding was studied in 37 patients fulfilling Research Diagnostic Criteria for major depressive disorder, examined before and after four weeks of treatment with minaprine 200 mg/day, and in 19 healthy controls." | 3.67 | Platelet 3H-imipramine binding and response to minaprine in patients with major depression. ( Kemali, D; Maj, M; Mastronardi, P; Palomba, U; Romano, M; Ventra, C, 1988) |
| "Minaprine was better tolerated than imipramine according to the physicians' tolerance rating (p < 0." | 2.68 | Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders. ( Robin, JL; Salzmann, E, 1995) |
| "One hundred and twelve patients suffering from moderate to severe major depression (DSM III) were enrolled into a study to compare the antidepressant activity and side effect profiles of two dosage groups of minaprine (200 mg and 300 mg per day) and one of imipramine (150 mg per day) in psychiatric practice." | 2.67 | Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine. ( Baldwin, DS; Herrington, RN; Livingston, HM; Montgomery, SA; Patel, A; Priest, RG; Steinert, J, 1991) |
| "Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of anticholinergic effects, cardiotoxicity, drowsiness, and weight gain." | 2.66 | Minaprine: an anticholinergic-free antidepressant? Results of a controlled trial of mianserin. ( Wheatley, D, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salzmann, E | 1 |
| Robin, JL | 1 |
| Priest, RG | 2 |
| Hawley, CJ | 1 |
| Kibel, D | 1 |
| Kurian, T | 1 |
| Montgomery, SA | 2 |
| Patel, AG | 1 |
| Smeyatsky, N | 1 |
| Steinert, J | 2 |
| Boyer, W | 1 |
| Norman, TR | 1 |
| Judd, FK | 1 |
| Burrows, GD | 1 |
| Wheatley, D | 2 |
| Baldwin, DS | 1 |
| Patel, A | 1 |
| Herrington, RN | 1 |
| Livingston, HM | 1 |
| Rampello, L | 1 |
| Nicoletti, G | 1 |
| Raffaele, R | 1 |
| Amsterdam, JD | 1 |
| Dunner, DL | 1 |
| Fabre, LF | 1 |
| Kiev, A | 1 |
| Rush, AJ | 1 |
| Goodman, LI | 1 |
| Bohacek, N | 2 |
| Ravic, M | 2 |
| Bizière, K | 2 |
| Maj, M | 1 |
| Mastronardi, P | 1 |
| Palomba, U | 1 |
| Romano, M | 1 |
| Ventra, C | 1 |
| Kemali, D | 1 |
1 review available for minaprine and Depression, Endogenous
| Article | Year |
|---|---|
New pharmacological approaches to the management of depression: from theory to clinical practice.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Fluoxetine; Humans; Moclobemide; Pyridazines | 1992 |
10 trials available for minaprine and Depression, Endogenous
| Article | Year |
|---|---|
Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Dose-Response Relationsh | 1995 |
Recovery from depressive illness does fit an exponential model.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; H | 1996 |
Antidepressant response follows an exponential decay curve: replication and extension.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; D | 1997 |
Minaprine in depression. A controlled trial with amitriptyline.
Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Depressive Disorder; Female; Humans; Male; Mi | 1992 |
Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Bl | 1991 |
Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arousal; Brain; Clomipramine; Depres | 1991 |
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
Topics: Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Rel | 1989 |
Minaprine: an anticholinergic-free antidepressant? Results of a controlled trial of mianserin.
Topics: Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Mi | 1989 |
Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fe | 1987 |
A double-blind comparison of minaprine and imipramine in the treatment of depressed patients.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Pyridazines | 1986 |
1 other study available for minaprine and Depression, Endogenous
| Article | Year |
|---|---|
Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
Topics: Adult; Aged; Antidepressive Agents; Blood Platelets; Depressive Disorder; Female; Humans; Imipramine | 1988 |